ICU Medical, Inc.
ICUI
Market Cap$3.15B
Close$
$308.88
135.4% upside
Current Fair Value
135.4% upsideUndervalued by 135.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.15 Billion |
|---|---|
| Enterprise Value | $4.28 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.83 |
| Beta | 0.88 |
| Outstanding Shares | 24,645,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -85.15 |
|---|---|
| PEG | 32.12 |
| Price to Sales | 1.37 |
| Price to Book Ratio | 1.54 |
| Enterprise Value to Revenue | 1.8 |
| Enterprise Value to EBIT | 38.1 |
| Enterprise Value to Net Income | -116 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 0.67 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About ICU Medical, Inc.
9,000 employees
CEO: Vivek Jain ICU Medical, Inc. is a San Clemente, California-based company with global operations that develops, manufactures, and sells medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical¡¯s products a...